IBD Sector Leader Breaks Out On First China Policy Shift In 14 Years
Sector leader Atour Lifestyle has been riding the China stimulus wave as it hovers near a buy point and all-time high. The post IBD Sector Leader Breaks Out On First China Policy Shift In 14 Years appeared first on Investor's Business Daily.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
Meta stock and Nvidia peer Broadcom are among among five S&P 500 stocks on IBD Leaderboard that are near buy points. The post Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points appeared first on Investor's Business Daily.
Spyre: Extended Half-Life Tech To Become Differentiating Factor For IBD Targeting
Spyre Therapeutics, Inc. interim data from the phase 1 study, using SPY001 in healthy volunteers, is expected by the end of 2024. SPY001 is an a4b7 inhibitor being developed to target IBD like Crohn's Disease and Ulcerative Colitis. The Crohn's Disease treatment market is projected to reach a value of $17.80 billion by 2033.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Making its debut on 07/10/2017, smart beta exchange traded fund Inspire Corporate Bond ETF (IBD) provides investors broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Eli Lilly acquires IBD drug developer Morphic in $3.2bn deal
Eli Lilly and Co (NYSE:LLY) has struck a deal to acquire Morphic Holding Inc (NASDAQ:MORF), a maker of inflammatory bowel disease (IBD) drugs, for approximately $3.2 billion. On a per-share basis the deal is priced at $57, to be paid in cash.
Cream of the Crop Part III: 3 (More) Must-Buy Stocks From IBD's Top 50
As I've noted in a few past columns, “Investor's Business Daily's IBD 50 is ‘a weekly, rules-based, computer-generated stock index.'” Moreover, the stocks on the list tend to be fundamentally strong and have top-notch growth outlooks.
Best Growth Stocks To Buy And Watch: See Updates To IBD Watchlists
Where can you find the best growth stocks to buy and watch? Start by checking the IBD 50, IBD Sector Leaders, IBD Big Cap 20, IPO Leaders and Stock Spotlight. You'll also find stocks like Microsoft (MSFT), ServiceNow (NOW) and PayPal (PYPL) whose track records of stable earnings growth have earned them a spot on IBD Long-Term Leaders. Be sure to check this page each day to see which stocks have just been added or removed from those screens. IBD stock lists, which have a history of beating the S&P 500, are based on our proprietary CAN SLIM Investing System, which helps identify today's most promising growth stocks by identifying those that are displaying the same traits that the best-performing stocks typically show in the early stages of a big move. But never buy a stock simply because it's on one of IBD's screens. Always do your own research and run all the stocks you're tracking through a buying checklist. And you can also use IBD's simple three-step routine to stay in sync with market conditions and make sure you have today's best growth stocks on your radar. Get Timely Buy And Sell Alerts With Leaderboard YOU MIGHT ALSO LIKE: Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros Looking For The Next Breakout Stocks? Start Here Which Companies Are Now Outperforming 95% Of All Stocks? Want Weekly Tips On Investing? Get The 'How To Invest' Newsletter How To Buy Stocks | Buying Checklist When To Sell Stocks | Selling Checklist
Cryptocurrency Prices And News: Ethereum Spikes On ETF Approval Chatter
Cryptocurrency News: Cryptocurrency prices leapt Monday after Bloomberg increased its odds that the Securities and Exchange Commission will approve spot ethereum ETFs. Elsewhere, bitcoin spiked back to $70,000 and could test its record highs this week, one analyst says. Bloomberg ETF analysts Eric Balchunas and James Seyffart on Monday increased their odds that the SEC will approve VanEck's spot ethereum application to 75% from 25%. Nine issuers, including VanEck and ARK Investment Management, have filed with the SEC to list spot bitcoin ETFs. The SEC will approve or deny the first round 19b-4s this week, with votes on VanEck and ARK's filings on Wednesday and Thursday, respectively. The 19b-4 forms and S-1 registration statements must both be approved for ETFs to launch. "Hearing chatter this afternoon that SEC could be doing a 180 on this (increasingly political issue)," Balchunas posted on social media platform X. "So now everyone scrambling (like us everyone else assumed they'd be denied). "We also need S-1 approvals," Seyffart said online. He noted that it could be weeks to months before S-1 filings are actually approved. "That said, if we're correct and see these theoretical approvals later this week. It should mean that S-1 approvals are a matter of 'when' not 'if'," Seyffart added. Bitcoin on April 19 completed its fourth halving event, which slashed the rewards doled out to miners. Bitcoin's price has historically risen in the months following previous halvings, but analysts are divided on the impact this year's event will have. Elsewhere, Sam Bankman-Fried on March 28 was sentenced to 25 years in prison for his role in the 2022 collapse of crypto exchange FTX. The strong of new highs is rooted in the industry's historic step forward on Jan. 11. That was the first trading day after the SEC approved 11 bitcoin ETF applications, which included issuers ARK Invest (ARKK), BlackRock (BLK), Grayscale, VanEck and more. Coinbase serves as the custodian for a majority of the new ETF issuers. How are crypto custodians keeping digital assets secure? The Best Bitcoin, Cryptocurrency ETFs To Watch And Buy Click here to jump to more on today's Cryptocurrency News. Bitcoin on Monday jumped to $69,500, marking a 5% gain over the last 24 hours. Bitcoin peaked at $70,399 intraday Monday before easing. On March 14 bitcoin hit a new all-time high of $73,798. The cryptocurrency is below its prior peak of $68,990 set in November 2021. Bitcoin had spiked to $49,000 January 11 on the ETF launch day but then fell back into its early December 2023 level prior to the SEC announcement. The world's largest cryptocurrency rebounded about 157% in 2023. Bitcoin is now up about 65% so far this year. Ethereum spiked to $3,500 late Monday, rallying nearly 14% over the last 24 hours. Ethereum is trending back toward its March 12, 52-week high of $4,092. The No. 2 crypto well below its November 2021 peak above $4,800. Ethereum on March 8 crossed its $4,000 level for the first time in 26 months. Still, ETH soared 53% in 2024. Scroll down for more cryptocurrency news and price updates. Digital asset investments are extremely volatile. While cryptocurrency's fundamentals and technical indicators may differ, investors should focus on the same key objectives. First, stay protected by learning when it's time to sell, cut losses or capture profits. Second, prepare to profit if the cryptocurrency starts to rebound. Despite their original promise, cryptocurrencies haven't acted as hedges against inflation. Instead, they've trended with the broader indexes. Read The Big Picture and Market Pulse to track daily market trends. View IBD's Best Cryptocurrencies And Crypto Stocks To Buy And Watch page to help navigate the world of digital asset investments. Want a deeper dive into crypto? Check out the What Is Cryptocurrency? explainer page. How Bitcoin's Upcoming Halving Differs From The Crypto's Previous Cycles European Central Bank Cranks Up Bitcoin Criticism You Say Bitcoin Is Digital Gold? Maybe It's Digital Pearls Want market-driving info delivered straight to your inbox? Sign up for IBD's new daily newsletter by clicking the image below. YOU MIGHT ALSO LIKE: Get Stock Lists, Stock Ratings And More With IBD Digital Find Stocks To Buy And Watch With IBD Leaderboard Identify Bases And Buy Points With MarketSmith Pattern Recognition Use Swing Trading Strategies To Find Opportunities & Manage Risk
Wix Stock Surges On Earnings Beat, Raised Outlook And New Buyback
Wix (WIX) stock surged Monday after the provider of website creation services reported first quarter profit and revenue that topped estimates. The company raised its full-year revenue outlook. The Israel-based company said Q1 profit rose 42% to $1.29 a share, topping estimate of $1.05 per share. Revenue climbed 12% to $420 million, topping estimates of $418 million. The company said it's in the process of authorizing a new $225 million buyback of Wix stock. On the stock market today, Wix stock jumped 23.8% to close at 168.02. Heading into the Wix earnings report, the company owned an entry point of 146.21 from a cup base. Shares soared past a 5% buy zone on Monday. Wix raised its full year revenue outlook to a range of $1.738 billion to $1.761 billion, or 13% growth. Q1 bookings came in at $457.3 million, above estimates of $453.4 million. "Q1 bookings beat street by $6 million," said Jefferies analyst Brent Thill in a report. "Fiscal 2024 bookings guidance was raised by $13 million at the midpoint to 12% to 14% growth." Wix's website design and hosting services compete with GoDaddy (GDDY). Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on artificial intelligence, cybersecurity and cloud computing. YOU MAY ALSO LIKE: Want To Trade Options? Here Are The Basics To Get You Started IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today Learn How To Time The Market With IBD's ETF Market Strategy Monitor IBD's "Breaking Out Today" List For Companies Hitting New Buy Points
Viking Holdings, IBD Stock Of The Day, Breaks Out; Cruise Lines Sail On Norwegian Guidance
Viking Holdings is the IBD Stock Of The Day for Monday. Shares of the newly publicly traded parent of Viking Cruises are breaking out of a short IPO base. Viking and other cruise stocks sailed higher after Norwegian Cruise Line Holdings (NCLH) hiked its outlook. Los Angeles-based Viking Holdings (VIK) debuted on the New York Stock Exchange on May 1 at 24 per share. The IPO raised about $1.5 billion, making it the largest public offering since Arm Holdings (ARM) launched in September, according to data from IPO research firm Renaissance Capital. Viking was founded in 1997 and operates a fleet of nearly 100 smaller ships for luxury river, ocean and lake cruises across the globe. The company focuses primarily on Europe and the Mediterranean with niche, upscale experiences that feature art, science, history, culture and cuisine to target an older, wealthier audience. Viking's European river vessels have an average capacity of about 190 passengers and its ocean liners hold about 930 passengers. The company's typical passenger load pales in comparison to the 3,000 load of average cruise ships. Meanwhile, cruise demand is expected to grow from 31.5 million cruise travelers in 2023 to 35.7 million in 2024, according to Expedia Cruises. Viking shares on Monday surged 4.2% to 29.68, breaking out past an official 29.46 buy point for a new IPO base on the weekly chart, MarketSurge data shows. However, Viking releases its Q1 results early on May 29. That will be its first report as a public company. FactSet estimates are not yet available for the report. Investors can take a position in VIK stock, but won't have a lot of time to build a cushion before earnings. Viking stock ranks 17th in the Leisure-Services Group, according to IBD Stock Checkup. Royal Caribbean (RCL) leads the IBD industry group, which ranks 108th out of the 197 groups tracked by IBD. VIK stock's relative strength line has climbed in recent weeks. The stock has a 70 RS Rating out of a best-possible 99. Norwegian Cruise Line Holdings hiked its outlook Monday ahead of its investor day presentation. The Miami-based cruise line announced its new "Charting the Course" strategy, which includes investment initiatives in the company culture and employees, guest product offerings, Norwegian's growth platform, as well as optimizing performance. By the end of 2026, Norwegian expects to achieve adjusted earnings of $2.45 per share, representing a two-year compound annual growth rate of over 30% from 2024 to 2026. Norwegian plans to achieve an adjusted operational EBITDA margin of about 39% to approach historical levels. The company by the end of 2026 also intends to reduce its greenhouse gas emissions by 10% from 2019 baseline levels. "We have continued to see very strong demand and record bookings," CFO Mark Kempa said in the release. "We are now thrilled to launch this financial plan by setting long-term targets with increased 2024 guidance, putting ourselves on solid footing to enhance shareholder value in the coming years." Norwegian also raised its 2024 outlook based on its 2026 targets. The company now expects adjusted earnings to surge 103% to $1.42 per share, up from its prior forecast of $1.32 per share. Norwegian guided net yield growth to rise 7.2%, compared with the prior guidance of 6.4% growth. Norwegian now sees 2024 adjusted EBITDA increasing 23.6% to $2.3 billion. The cruise line guided adjusted EBITDA of $2.25 billion with its first-quarter results on May 1. Norwegian maintained its occupancy guidance of around 105.1% capacity. NCLH stock leapt 8.3% Monday to rebound back above its 21-day exponential moving average and 10-day lines. Shares are trading just shy of their 200-day line. Norwegian stock had fallen 14.8% in 2024. Royal Caribbean spiked 5% Monday on the Norwegian Cruise Line announcement. RCL stock is extended above a buy zone for a cup base following a late March breakout. Monday's move offered current investors an add-on entry as RCL cleared a few weeks of resistance. Royal Caribbean shares have rallied 15% year to date. Carnival (CCL) jumped 7% Monday to bounce strongly above its 50-day and 200-day lines. CCL stock is off 13.7% so far this year. You can follow Harrison Miller for more stock news and updates on X/Twitter @IBD_Harrison YOU MAY ALSO LIKE: Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists Looking For The Next Big Stock Market Winners? Start With These 3 Steps Join IBD Live And Learn Top Chart Reading And Trading Techniques From Pros Learn How To Time The Market With IBD's ETF Market Strategy
